Thank you for your interest in submitting an abstract for consideration of a poster at the Hepatology and Liver Transplantation: Today and Tomorrow 2025 in Orlando, Florida. Please complete the fields below and click submit at the end of the form. You should receive a confirmation e-mail after you click submit. 

Accepted abstract recipients will be chosen from all abstracts received by Friday, May 9, 2025 submission deadline. Notification of acceptance can occur within 1-2 weeks of submission prior to this deadline and no later than 1 week after this deadline.

Application:

  • All fields are required, omitting this information may lead to rejection of your abstract. Abstract presenters are required to attend the full meeting.
  • Additional authors cannot be added after the abstract has been submitted.
  • NO graphs or references allowed - text only please.
  • Submission of an abstract does not automatically register you for the course.

Abstracts can be submitted in the following formats:

  • Research Abstracts: All types of gastroenterology and hepatology-related research are eligible for submission and should address scientific questions, detail clinical observations, or contain preliminary scientific data.  Also research into  systems-based practice innovation or improvements will be reviewed for acceptance. 
  • Clinical Cases:  These may include challenging clinical cases encountered in practice (ie., case reports) of those encountered in clinical practice. Case reports must include uniqueness of the case, clinical findings presented, outcomes documented, and "take-away" lessons (teaching points).

Abstract Eligibility:
Original abstracts that either have or have not been presented at other meetings will be considered for the conference.  Abstracts based upon published papers will also be considered. 

Number of Entries:
A participant may be the primary author on no more than two abstracts, however, he or she may be a contributing author on any number of abstracts.

Notification of Results:
Accepted abstracts will be notified by email. All primary authors will be notified by email no later than 2 weeks following their submission, if their submission has been selected for the poster session and details regarding poster set-up will follow.  Accepted abstract recipients must still register for the meeting to attend. 

Inquiries:
For further information, contact Iwona Bukato at flacmeabstracts@mayo.edu.

Presenter

Presentation Title

Daria B. Crittenden

Long-Term Efficacy and Safety of Open-Label Seladelpar Treatment in Patients With Primary Biliary Cholangitis: Pooled Interim Results for up to 3 Years from the ASSURE Study

Daria B. Crittenden

Efficacy and Safety of Seladelpar in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis in the Phase 3 Placebo-Controlled RESPONSE Trial

Alex Danielson, MD

A Case of Wilson’s Disease with Severe Neurological Involvement

Mohamad Rani Hassoun, M.D.

An atypical case of toxoplasmosis in an immunocompetent host with unexplained hepatosplenomegaly

Nichole C. Henkes

Combined Cardiac and Liver MR in Fontan Patients: "All in One" Analysis

Ingrid Hirte, M.D.

Rare Syphilis Manifestations: A Case Report of Syphilitic Hepatitis

Fares Jamal, MD

Management of Severe Thrombocytopenia in a Liver Transplant Candidate with End-Stage Liver Disease

Vijayvardhan Kamalumpundi, MD

Refractory Parastomal Variceal Bleeding in CVID-Associated Nodular Regenerative Hyperplasia: A Therapeutic Challenge

Matthew Ledenko

The Cost of Hunger: Food Insecurity and Deaths from Primary Liver Cancers in the United States

Shirley Y. Lugardo Echevarria, MD

Reversing the Irreversible? Fibrosis Regression in Cirrhosis with Semaglutide: A Case Report

Graciela Luna, MD

The Bilirubin Blues: Plasma Exchange for Bilirubin Nephropathy

Bibek Saha

Hepatic Adenomatosis Transformation to Hepatocellular Carcinoma Secondary to Exogenous Testosterone Use

Bibek Saha

Recurrent Acute Cholangitis Secondary to Caroli Syndrome Managed with Liver Transplantation

Shahin, Tala B, MD

WORSENING HEPATOPULMONARY SYNDROME POST LIVER TRANSPLANTATION REQUIRING RETRANSPLANTATION

Rineetha Tandra

Culture-Negative Hepatic Cyst Infection in a Renal Transplant Recipient with ADPKD: A Diagnostic and Therapeutic Challenge

Jennifer Trube DO PGY1

Metabolic Mayhem: The Lactic Acid Chronicles in Acute Hepatic Decompensation

Asrita Vattikonda, MD

Cysto-Duodenal Fistula: Who, What, When, Where, and Why?

Omar Zuhdi, MD

Abdominal Cocoon Syndrome -The Association Between Sclerosing Encapsulating Peritonitis and Liver Cirrhosis: A Review of the Current Literature

Omar Zuhdi, MD

Hepatotoxicity of Turmeric as a Popular Anti-Inflammatory Supplement: A Review of the Literature